GFM
DXCM icon

GF Fund Management’s DexCom DXCM Stock Holding History

GF Fund Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.97M Sell
88,596
-1,886
-2% -$126K 0.07% 123
2026
Q1 		$5.68M Sell
90,482
-2,343
-3% -$163K 0.1% 125
2025
Q4 		$6.16M Buy
92,825
+3,977
+4% +$257K 0.11% 134
2025
Q3 		$5.98M Buy
88,848
+1,780
+2% +$141K 0.11% 133
2025
Q2 		$7.6M Buy
87,068
+2,694
+3% +$211K 0.15% 118
2025
Q1 		$5.76M Buy
84,374
+1,305
+2% +$106K 0.14% 129
2024
Q4 		$6.46M Buy
+83,069
New +$6.15M 0.14% 123

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

GF Fund Management's DXCM Position: Q2 2026 in Review

GF Fund Management reduced its DexCom (DXCM) stake by 2.1% in Q2 2026, selling an estimated $126K and leaving 88,596 shares worth $5.97M. The position accounts for 0.07% of the portfolio, ranked #123.

GF Fund Management first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.6M in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • GF Fund Management held 88,596 shares of DexCom worth $5.97M as of Q2 2026.
  • GF Fund Management sold 1,886 DexCom shares in Q2 2026, an estimated $126K.
  • DexCom made up 0.07% of GF Fund Management's portfolio in Q2 2026, its #123 holding.
  • GF Fund Management first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's DexCom position peaked at $7.6M in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.